Archive · 14 Sep 2025
Expert: Cancer Vaccines Prevent Recurrence, Not Initial Onset
Doctors are developing vaccines to help prevent cancer from returning in people who have already been treated.
These vaccines are different from those that prevent cancer in the first place.
They use immunotherapy to teach the body's defense system to find and destroy any remaining cancer cells.
This was discussed at a conference focused on colorectal cancer, which is becoming more common.
Doctors are also working on tailoring treatments to each patient, which is called personalized medicine.
Over 200 experts attended the conference to discuss the latest treatments.
Cancer vaccines aim to prevent cancer recurrence, not initial onset.
These are therapeutic cancer vaccines, not preventative ones.
The vaccines utilize immunotherapy to train the immune system.
The conference focused on Colorectal Cancers (CRC).
The event involved over 200 medical professionals.
- Who
- Dr. Rajeev Jayadevan, Dr. Arun R Warrier, and medical professionals
- What
- Discussion of therapeutic cancer vaccines for recurrence and personalized medicine
- When
- At the second annual GIOS conference
- Where
- Kerala, India
- Why
- To discuss advancements in cancer treatment, specifically CRC.
- Focus
- Cancer recurrence prevention
- Type
- Therapeutic cancer vaccines
- Mechanism
- Immunotherapy; trains immune system
- Event
- GIOS conference
- Conference Focus
- Colorectal Cancers (CRC)
- Participants
- Oncologists, gastroenterologists, and medical professionals